UTHR
United Therapeutics Corp

2,468
Mkt Cap
$37.77B
Volume
544,886.00
52W High
$548.12
52W Low
$266.98
PE Ratio
19.22
UTHR Fundamentals
Price
$536.12
Prev Close
$532.82
Open
$533.83
50D MA
$487.58
Beta
0.46
Avg. Volume
376,933.71
EPS (Annual)
$27.86
P/B
3.30
Rev/Employee
$2.27M
$20,418.98
Loading...
Loading...
News
all
press releases
Promising Biotech Stocks To Add to Your Watchlist - March 15th
Danaher, Vertex Pharmaceuticals, bioAffinity Technologies, Moderna, United Therapeutics, ImmunityBio, and argenex are the seven Biotech stocks to watch today, according to MarketBeat's stock screener...
MarketBeat·5h ago
News Placeholder
More News
News Placeholder
Portolan Capital Management LLC Sells 12,687 Shares of United Therapeutics Corporation $UTHR
Portolan Capital Management LLC trimmed its stake in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 41.2% in the third quarter, according to the company in its most recent...
MarketBeat·2d ago
News Placeholder
Comerica Bank Sells 4,028 Shares of United Therapeutics Corporation $UTHR
Comerica Bank decreased its position in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 2.5% in the third quarter, according to its most recent Form 13F filing with the...
MarketBeat·2d ago
News Placeholder
United Therapeutics Stock Surges 32% in 6 Months: Here's Why
UTHR shares jump 32% in six months as Tyvaso sales surge, earnings grow and Phase III TETON-2 data open a potential new market in IPF.
Zacks·2d ago
News Placeholder
Van ECK Associates Corp Purchases 29,297 Shares of United Therapeutics Corporation $UTHR
Van ECK Associates Corp increased its position in United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 282.7% during the 3rd quarter, according to the company in its most recent Form 13F...
MarketBeat·2d ago
News Placeholder
Korea Investment CORP Has $5.90 Million Holdings in United Therapeutics Corporation $UTHR
Korea Investment CORP trimmed its holdings in shares of United Therapeutics Corporation (NASDAQ:UTHR - Free Report) by 54.7% during the 3rd quarter, according to its most recent disclosure with the...
MarketBeat·3d ago
News Placeholder
Biotech Stocks To Watch Today - March 12th
Danaher, Abivax, Vertex Pharmaceuticals, Moderna, argenex, BioNTech, and United Therapeutics are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool. Biotech stocks...
MarketBeat·3d ago
News Placeholder
Cantor Fitzgerald Forecasts Strong Price Appreciation for United Therapeutics (NASDAQ:UTHR) Stock
Cantor Fitzgerald upped their price objective on shares of United Therapeutics from $525.00 to $625.00 and gave the stock an "overweight" rating in a research report on Thursday...
MarketBeat·3d ago
News Placeholder
United Therapeutics (NASDAQ:UTHR) CEO Sells $5,125,630.00 in Stock
United Therapeutics Corporation (NASDAQ:UTHR - Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the firm's stock in a transaction dated Wednesday, March 11th. The shares were sold at an...
MarketBeat·3d ago
News Placeholder
Best Biotech Stocks To Consider - March 11th
Vertex Pharmaceuticals, BioNTech, Danaher, Moderna, Dianthus Therapeutics, argenex, and United Therapeutics are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...
MarketBeat·4d ago
<
1
2
...
>

Latest UTHR News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.